You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》花旗削藥明康德(02359.HK)目標價至90元 美國法案仍不確定
花旗發表報告指,藥明康德(02359.HK)2024財年指引令人失望,進一步削弱市場信心,令增長前景變得不確定。根據2024財年指引和與美國制裁相關的不確定性,該行將2024和2025財年收入預測分別下調22%和35%,每股盈利預測分別下調19%和34%。該行料長遠收入增長將更加溫和,因此將目標價由175大削至90元。 花旗指,藥明康德2023財年營收為403億人民幣,按年增長2.5%,符合預期。淨利潤為96億人民幣,按年增長9%,與預期相差6%。 報告指,藥明康德管理層預計2024年收入將達到383億至405億人民幣,明顯低於預期。至於2024年經調整非國際財務報告準則淨利潤率料將保持穩定。管理層指出,已將與美國法案相關的不確定性因素納入2024年的疲軟指引中,但認為不會產生直接影響。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account